Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01729845
Title Decitabine Followed By Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Fred Hutchinson Cancer Research Center
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Kadlec Clinic Hematology and Oncology Kennewick Washington 99336 United States Details
EvergreenHealth Medical Center Kirkland Washington 98033 United States Details
Fred Hutch/University of Washington Cancer Consortium Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field